Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.

Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L, Waugh N.

Health Technol Assess. 2010 Feb;14(11):iii-iv, xi-xvi, 1-181. doi: 10.3310/hta14110. Review.

2.

Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.

Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S.

Health Technol Assess. 2010 Jul;14(36):1-248. doi: 10.3310/hta14360. Review.

3.

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N.

Health Technol Assess. 2004 Oct;8(43):iii, 1-171. Review.

4.

Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.

Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J.

Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170. Review.

5.

Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.

Farrar D, Tuffnell DJ, West J, West HM.

Cochrane Database Syst Rev. 2016 Jun 7;(6):CD005542. doi: 10.1002/14651858.CD005542.pub3. Review.

PMID:
27272351
6.

Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.

Golden SH, Sapir T.

J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. Review.

PMID:
22984955
7.

Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.

Warren E, Weatherley-Jones E, Chilcott J, Beverley C.

Health Technol Assess. 2004 Nov;8(45):iii, 1-57. Review.

8.

The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation.

Black C, Cummins E, Royle P, Philip S, Waugh N.

Health Technol Assess. 2007 Sep;11(33):1-126. Review.

9.

Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis.

Ranasinghe PD, Maruthur NM, Nicholson WK, Yeh HC, Brown T, Suh Y, Wilson LM, Nannes EB, Berger Z, Bass EB, Golden SH.

J Womens Health (Larchmt). 2015 Mar;24(3):237-49. doi: 10.1089/jwh.2014.4939. Epub 2015 Feb 25. Review.

10.

Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.

Roze S, Smith-Palmer J, Valentine W, de Portu S, Nørgaard K, Pickup JC.

Diabet Med. 2015 Nov;32(11):1415-24. doi: 10.1111/dme.12792. Epub 2015 May 28. Review.

PMID:
25962621
11.

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.

Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.

PMID:
22777524
12.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.

PMID:
22258980
13.

Self-monitoring of blood glucose in type 2 diabetes: systematic review.

Clar C, Barnard K, Cummins E, Royle P, Waugh N; Aberdeen Health Technology Assessment Group.

Health Technol Assess. 2010 Mar;14(12):1-140. doi: 10.3310/hta14120. Review.

14.

Methods for Insulin Delivery and Glucose Monitoring: Comparative Effectiveness [Internet].

Golden SH, Brown T, Yeh HC, Maruthur N, Ranasinghe P, Berger Z, Suh Y, Wilson LM, Haberl EB, Bass EB.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Jul.

15.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

16.

Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation.

Czoski-Murray C, Warren E, Chilcott J, Beverley C, Psyllaki MA, Cowan J.

Health Technol Assess. 2004 Apr;8(13):iii, ix-x, 1-91. Review.

17.

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.

Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A.

Diabetologia. 2008 Jun;51(6):941-51. doi: 10.1007/s00125-008-0974-3. Epub 2008 Mar 20. Review.

PMID:
18351320
18.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

19.

Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.

Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A.

Cochrane Database Syst Rev. 2014 Feb 14;(2):CD009122. doi: 10.1002/14651858.CD009122.pub2. Review.

PMID:
24526393
20.

Screening for type 2 diabetes: literature review and economic modelling.

Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.

Supplemental Content

Support Center